3595 studies found for:    Japan
Show Display Options
Rank Status Study
1 Completed
Has Results
A Phase 2 Study of Tapentadol Extended-Release (JNS024ER) ) in Japanese Participants With Chronic Pain Due to Diabetic Neuropathic Pain or Postherpetic Neuralgia
Conditions: Pain;   Diabetic Neuropathies;   Neuralgia;   Postherpetic Neuralgia
Interventions: Drug: Tapentadol;   Drug: Placebo
2 Completed
Has Results
Study In Patients With Depression Not Responding to Selective Serotonin Re-uptake Inhibitors
Condition: Major Depressive Disorder (MDD)
Interventions: Drug: Placebo;   Drug: 323U66 (Bupropion Hydrochloride Sustained Release)
3 Terminated Dose Response Study in Japanese Patients
Condition: Type 2 Diabetes
Intervention: Drug: Tesaglitazar
4 Recruiting Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Biological: BMS-188667;   Drug: Mycophenolate mofetil;   Drug: Prednisone;   Biological: Placebo matching with BMS-188667
5 Recruiting Prognostic Study of Gastric MALT Lymphoma After Eradication of Helicobacter Pylori
Condition: Gastric Low-grade MALT Lymphoma With Helicobacter Pylori Positive
Intervention: Drug: Rabeprazole Sodium
6 Recruiting DISCOVERing Treatment Reality of Type 2 Diabetes in Real World Setting in Japan
Condition: Type 2 Diabetes Mellitus
7 Recruiting Study to Evaluate the Safety and Efficacy of Two Drug Regimens in Subjects With Moderate to Severe Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Drug: Adalimumab;   Other: Placebo
8 Completed Efficacy and Safety of Vildagliptin as add-on Therapy to Metformin in Patients With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Vildagliptin;   Drug: Placebo
9 Active, not recruiting A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
Condition: Peripheral Artery Disease
Interventions: Drug: Ticagrelor;   Drug: Clopidogrel
10 Completed Double-Blind Study of Miglitol in Japanese With type2 Diabetes
Condition: Type 2 Diabetes Mellitus
Intervention: Drug: miglitol
11 Completed
Has Results
A Safety and Efficacy Study of Oral Tapentadol Extended-Release in Japanese Participants
Condition: Neoplasms
Interventions: Drug: Tapentadol ER;   Drug: Morphine SR
12 Completed Randomized, Double-blind Study to Evaluate the Tolerability of 2 Different Titration Methods of Rivastigmine Patch in AD Patients (MMSE 10-20)
Condition: Alzheimer's Disease
Interventions: Drug: Active Comparator;   Drug: ENA713
13 Completed A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults With Asthma
Condition: Asthma
Intervention: Drug: Tralokinumab
14 Completed
Has Results
Long-Term Study of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder (AD/HD)
Condition: Attention Deficit Hyperactivity Disorder
Intervention: Drug: Atomoxetine hydrochloride
15 Completed Long-term Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment (Planetarium Study)
Condition: Gastric Ulcers Duodenal Ulcers Caused by Low-dose Aspirin
Intervention: Drug: E3810
16 Enrolling by invitation Guidewire for Chronic Total Occlusion
Condition: Coronary Occlusion
Intervention: Device: Percutaneous coronary intervention (PCI)
17 Completed
Has Results
A Phase II/III Study of SEP-190 (Eszopiclone) in Patients With Primary Insomnia (Study 190-126)
Condition: Primary Insomnia
Interventions: Drug: Eszopiclone 1 mg;   Drug: Eszopiclone 2 mg;   Drug: Eszopiclone 3 mg;   Drug: Placebo;   Drug: Zolpidem Tartrate 10 mg
18 Completed
Has Results
Maintenance Study of Certolizumab Pegol (CZP) in Crohn's Disease
Condition: Crohn's Disease
Intervention: Biological: Certolizumab pegol (CZP)
19 Completed Efficacy and Safety of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Non-steroidal Anti-inflammatory Drug (NSAID)
Conditions: Gastric Ulcers;   Duodenal Ulcers
Interventions: Drug: TAK-438;   Drug: Placebo;   Drug: Lansoprazole
20 Completed Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)
Condition: Acute Coronary Syndrome
Interventions: Drug: lixisenatide (AVE0010);   Drug: placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years